🇺🇸 FDA
Patent

US 7074782

Carbamate caspase inhibitors and uses thereof

granted A61PA61P1/04A61P1/16

Quick answer

US patent 7074782 (Carbamate caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/06